TrialBlood advances2024

Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse.

Peter Voorhees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.